A tumor-on-a-chip model reveals and targets reciprocal macrophage-NK cell crosstalk to advance immunotherapy screening

Researchers have developed a 'tumor-on-a-chip' platform to study the immunosuppressive interactions between macrophages and NK cells in liver tumors. This model successfully identified drug combinations that overcome resistance to immunotherapy, offering a tool for personalized cancer treatment.